STOCK TITAN

CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

CV Sciences (OTCQB: CVSI), a leading consumer wellness company specializing in hemp extracts and natural products, has announced its plans to release financial results for the second quarter of 2024 on Tuesday, August 13, 2024, before the stock market opens. The company will host a conference call with investors at 7:00 a.m. Pacific Time on the same day.

Investors can access the webcast through the company's Investor Relations website or directly via a provided link. For those preferring to participate by phone, U.S. callers can dial (877) 407-0784, while international callers should use (201) 689-8560. A replay of the call will be available until August 20, 2024.

CV Sciences (OTCQB: CVSI), un'azienda leader nel settore del benessere dei consumatori specializzata in estratti di canapa e prodotti naturali, ha annunciato i suoi piani per rilasciare i risultati finanziari del secondo trimestre del 2024 il martedì 13 agosto 2024, prima dell'apertura del mercato azionario. L'azienda ospiterà una call conference con gli investitori alle 7:00 ora del Pacifico lo stesso giorno.

Gli investitori possono accedere al webcast tramite il sito web delle Relazioni con gli Investitori dell'azienda o direttamente tramite un link fornito. Per coloro che preferiscono partecipare telefonicamente, i chiamanti statunitensi possono comporre il numero (877) 407-0784, mentre i chiamanti internazionali dovrebbero utilizzare il numero (201) 689-8560. Una registrazione della chiamata sarà disponibile fino al 20 agosto 2024.

CV Sciences (OTCQB: CVSI), una empresa líder en bienestar del consumidor especializada en extractos de cáñamo y productos naturales, ha anunciado sus planes para publicar resultados financieros del segundo trimestre de 2024 el martes 13 de agosto de 2024, antes de la apertura del mercado de valores. La empresa llevará a cabo una conferencia telefónica con los inversores a las 7:00 a.m. hora del Pacífico ese mismo día.

Los inversores pueden acceder a la transmisión web a través del sitio web de Relaciones con Inversores de la empresa o directamente a través de un enlace proporcionado. Para aquellos que prefieren participar por teléfono, los llamantes de EE. UU. pueden marcar el (877) 407-0784, mientras que los llamantes internacionales deben usar el (201) 689-8560. Se podrá acceder a una repetición de la llamada hasta el 20 de agosto de 2024.

CV 사이언스 (OTCQB: CVSI)는 대마 추출물 및 자연 제품을 전문으로 하는 선도적인 소비자 웰빙 회사로, 2024년 2분기 재무 결과2024년 8월 13일 화요일 주식 시장이 열리기 전에 발표할 계획이라고 발표했습니다. 회사는 같은 날 태평양 표준시 오전 7시에 투자자와 함께 컨퍼런스 콜을 진행할 예정입니다.

투자자들은 회사의 투자자 관계 웹사이트를 통해 또는 제공된 링크를 통해 웹캐스트에 접근할 수 있습니다. 전화로 참여를 원하는 분들은 미국 callers는 (877) 407-0784로 전화를 걸 수 있으며, 국제 callers는 (201) 689-8560를 사용해야 합니다. 통화 재생은 2024년 8월 20일까지 제공됩니다.

CV Sciences (OTCQB: CVSI), une entreprise leader dans le bien-être des consommateurs spécialisée dans les extraits de chanvre et les produits naturels, a annoncé ses projets de publier les résultats financiers du deuxième trimestre 2024 le mardi 13 août 2024, avant l'ouverture des marchés boursiers. L'entreprise organisera une conférence téléphonique avec les investisseurs à 7h00, heure du Pacifique, le même jour.

Les investisseurs peuvent accéder au webinaire via le site des Relations Investisseurs de l'entreprise ou directement via un lien fourni. Pour ceux qui préfèrent participer par téléphone, les appelants des États-Unis peuvent composer le (877) 407-0784, tandis que les appelants internationaux devraient utiliser le (201) 689-8560. Un enregistrement de l'appel sera disponible jusqu'au 20 août 2024.

CV Sciences (OTCQB: CVSI), ein führendes Unternehmen im Bereich Verbraucherwohlbefinden, das sich auf Hanfextrakte und Naturprodukte spezialisiert hat, hat seine Pläne angekündigt, die finanziellen Ergebnisse für das zweite Quartal 2024 am Dienstag, den 13. August 2024, vor der Eröffnung der Börse zu veröffentlichen. Das Unternehmen wird am selben Tag um 7:00 Uhr Pacific Time eine Konferenzschaltung mit Investoren ausrichten.

Investoren können über die Website der Investor Relations des Unternehmens auf das Webcast zugreifen oder direkt über einen bereitgestellten Link. Für diejenigen, die telefonisch teilnehmen möchten, können US-Anrufer die Nummer (877) 407-0784 wählen, während internationale Anrufer (201) 689-8560 verwenden sollten. Eine Wiederholung des Anrufs wird bis zum 20. August 2024 verfügbar sein.

Positive
  • None.
Negative
  • None.

SAN DIEGO, Aug. 7, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the second quarter ended June 30, 2024, before the stock market opens on Tuesday, August 13, 2024. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) that same day.

The webcast of the conference call will be available on the Investor Relations section of the Company's website at https://ir.cvsciences.com/news-events or directly at https://viavid.webcasts.com/starthere.jsp?ei=1676369&tp_key=2c558c26e6. The webcast will be archived for approximately 30 days. Investors interested in participating in the live call can also dial (877) 407-0784 from the U.S. or international callers can dial (201) 689-8560.  Please dial the conference telephone number 15 minutes prior to the start time due to increased demand for conference calls.

A telephone replay will be available approximately two hours after the call concludes and will be available through Tuesday, August 20, 2024, by dialing (844) 512-2921 from the U.S. or (412) 317-6671 from international locations, and entering confirmation code 13747169.

About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB:CVSI) is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other proven, science-backed, natural ingredients and products are sold at select retail locations throughout the U.S. and are the top-selling brands of hemp extracts in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry.  With a commitment to science, +PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov.  +PlusCBD™ was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. The Company's Cultured Foods™ brand provides a variety of 100% plant-based food products. Committed to crafting nutritious and flavorful alternatives, Cultured Foods™ caters to individuals seeking vegan, gluten-free, or flexitarian options for a wholesome and satisfying culinary experience. In addition, the Company owns Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. CV Sciences, Inc. has primary offices and facilities in San Diego, California, Grand Junction, Colorado, and Warsaw, Poland. The Company also operates a drug development program focused on developing and commercializing CBD-based novel therapeutics. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com

 FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risk and uncertainties. CV Sciences does not undertake any obligation to publicly update any forward-looking statements, except as required by applicable law. As a result, investors should not place undue reliance on such forward-looking statements.

CONTACT INFORMATION:

ir@cvsciences.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cv-sciences-inc-to-announce-second-quarter-2024-results-on-august-13-2024-302216516.html

SOURCE CV Sciences, Inc.

FAQ

When will CV Sciences (CVSI) release its Q2 2024 financial results?

CV Sciences (CVSI) will release its Q2 2024 financial results on Tuesday, August 13, 2024, before the stock market opens.

What time is CV Sciences' (CVSI) Q2 2024 earnings call scheduled for?

CV Sciences' (CVSI) Q2 2024 earnings call is scheduled for 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) on Tuesday, August 13, 2024.

How can investors access CV Sciences' (CVSI) Q2 2024 earnings call?

Investors can access CV Sciences' (CVSI) Q2 2024 earnings call via webcast on the company's Investor Relations website or by dialing (877) 407-0784 for U.S. callers or (201) 689-8560 for international callers.

Until what date will the replay of CV Sciences' (CVSI) Q2 2024 earnings call be available?

The replay of CV Sciences' (CVSI) Q2 2024 earnings call will be available until Tuesday, August 20, 2024.

CV SCIENCES INC

OTC:CVSI

CVSI Rankings

CVSI Latest News

CVSI Stock Data

9.03M
180.62M
0.02%
0%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
San Diego